Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
History
Science
Sports
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/0d/b8/70/0db87007-3e09-394e-5246-60810ea32ab3/mza_4040002773671845254.jpg/600x600bb.jpg
Dr. Chapa’s Clinical Pearls.
Dr. Chapa’s Clinical Pearls
1014 episodes
2 days ago
Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.
Show more...
Science
RSS
All content for Dr. Chapa’s Clinical Pearls. is the property of Dr. Chapa’s Clinical Pearls and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/384576/384576-1735598646387-c2aa97b9dfedc.jpg
Antenatal Steroids, and Baby Brains, Oh-MY!
Dr. Chapa’s Clinical Pearls.
36 minutes 39 seconds
1 month ago
Antenatal Steroids, and Baby Brains, Oh-MY!

Antenatal Corticosteroids (ACS) for Fetal Lung Maturation (and more) is an ever evolving saga. This is how science and medicine evolve, by always seeking more information. The effect of antenatal corticosteroids on neonatal/child neurodevelopmental outcomes is controversial and may be influenced by the gestational age at which exposure occurred. In this episode we will highlight TWO recent publications, one from May 2025 (JAMA Netw) and the other from June 2025 (Obstet Gynecol). The first adds data to the "Dose to Delivery interval" question for ACS benefit, and the second article relates to neurodevelopmental outcomes after exposure. Listen in for details.

Dr. Chapa’s Clinical Pearls.
Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.